Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT02477215 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: MLN9708
DRUG: Dexamethasone
DRUG: Bendamustine (multiple dose levels)
DRUG: Bendamustine (MTD)

Sponsor

Parameswaran Hari